BDTB Bodhi Tree Biotechnology Inc
Services-Management Consulting Services · OTC · SEC CIK 2041531 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY48.0%
TTM net income YoY44.9%
TTM EPS YoY-20.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-310.2%
Net margin-313.6%
FCF margin—
EBITDA margin—
Returns
ROE-161.5%
ROA-156.6%
ROIC (approx.)-899.0%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets24.6%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.00x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 |
|---|---|
| Income statement | |
| Revenue | $17,000 |
| SG&A expense | $164,618 |
| Operating income | -$147,618 |
| Pretax income | -$147,616 |
| Income tax | $2,050 |
| Net income | -$149,666 |
| EPS (basic) | -0.01 |
| EPS (diluted) | -0.01 |
| Weighted avg. shares (diluted) | 25.44M |
| Banking | |
| Net interest income | $2 |
| Balance sheet | |
| Cash & equivalents | $109,404 |
| Total assets | $119,161 |
| Total liabilities | $0 |
| Shareholders' equity | $119,161 |
| Shares outstanding | 25.44M |
| Cash flow statement | |
| Operating cash flow | -$150,166 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.